DPIIT recognised startup Government of India
Startup India
Mana Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹55.64 Cr
▼ 23% YoY
Net profit · FY 2025
₹32.1 Lakh
Net margin 0.6%
EBITDA · FY 2025
₹1.55 Cr
EBITDA margin 2.8%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹8.12 Cr
Issued & subscribed
Open charges
₹15.18 Cr
Satisfied ₹28.35 Cr
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
About Mana Pharma Private Limited
Data last updated:
Mana Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 June 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG2019PTC133266. Its GSTIN is 36AAMCM7302C1ZO (Telangana).
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹8.12 Cr. It is led by directors Bhaskaraiah Marri and Sailaja Bharatala.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹55.64 Cr, a decline of 23% compared to the previous year. For the same year it recorded a net profit of ₹32.1 Lakh (net margin 0.6%) and EBITDA of ₹1.55 Cr (EBITDA margin 2.8%). Revenue has grown at a compounded annual rate (CAGR) of 31% over three years and 72% over five years.
As per MCA filings, the company has open charges of ₹15.18 Cr and satisfied charges of ₹28.35 Cr on record.
Mana Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-09-0011784). For more details, the company can be reached via its website mana-pharma.com.
Company Details of Mana Pharma Private Limited
CIN U24230TG2019PTC133266
Registration Number 133266
Incorporation Date 10 June 2019
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Small
Udyam Registration UDYAM-TS-09-0011784
Recognitions & Rankings of Mana Pharma
MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-09-0011784
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address501 Anagha Enclave, Plot No.61 Kavuri Hills Phase – 1, Hyderabad, Telangana, India – 500033
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Mana Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Mana Pharma Private Limited
The main business activity of Mana Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Mana Pharma Private Limited FY 2025 filings available
Mana Pharma Private Limited reported revenue of ₹55.64 Cr (down 23% YoY) for FY 2025.
Revenue · FY 2025
₹55.64 Cr ▼ 23%
Net profit · FY 2025
₹32.1 Lakh margin 0.6%
EBITDA · FY 2025
₹1.55 Cr margin 2.8%
Compounded Annual Growth Rate (CAGR) of Mana Pharma Private Limited
Revenue CAGR growth
1 year
▼ 23%
3 years · compounded
▲ 31%
5 years · compounded
▲ 72%
EBITDA CAGR growth
1 year
▼ 3%
3 years · compounded
▲ 58%
5 years · compounded
▲ 52%
Revenue fell 23% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 72%. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Mana Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.55 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹32.1 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Mana Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Mana Pharma are in the company report.
Premium access
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Mana Pharma Private Limited
Mana Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhaskaraiah Marri Also directs: Mana Life Sciences Private Limited, Drug Genie LLP | Director | 10 Jun 2019 | 7 Years 4 Months | Current |
| Sailaja Bharatala | Director | 10 Jun 2019 | 7 Years 4 Months | Current |
Peer Comparison of Mana Pharma Private Limited
Mana Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Eurocrit Labs International Private Limited | ₹55.79 Cr (FY 2025) | •••• | •••• | 146.0% | •••• | Panchkula, Haryana, India |
| Elixir Extracts Private Limited | ₹55.72 Cr (FY 2025) | •••• | •••• | 43.0% | •••• | Muvattupuzha, Kerala, India |
| CS Performance Chemicals Private Limited | ₹55.72 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Dahej, Gujarat, India |
| Irrh Specialty Chemicals India Limited | ₹55.69 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | New Delhi, Delhi, India |
| Reshmika Minerals & Chemicals Private Limited | ₹55.66 Cr (FY 2024) | •••• | •••• | 15.0% | •••• | Pune, Maharashtra, India |
| Mana Pharma Private Limited this company | ₹55.64 Cr (FY 2025) | •••• | •••• | -23.0% | •••• | Hyderabad, Telangana, India |
| Tenax India Industrial Chemical Private Limited | ₹55.55 Cr (FY 2024) | •••• | •••• | -12.0% | •••• | Bengaluru, Karnataka, India |
| Prerana Ammonia and Chemicals Private Limited | ₹55.53 Cr (FY 2019) | •••• | •••• | 10.0% | •••• | Thane, Maharashtra, India |
| Margo Biocontrols Private Limited | ₹55.42 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | Tumkur, Karnataka, India |
| Aerol Formulations Private Limited | ₹55.39 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | New Delhi, Delhi, India |
| 3B Blackbio Biotech India Limited | ₹55.39 Cr (FY 2023) | •••• | •••• | -25.0% | •••• | Bhopal, Madhya Pradesh, India |
Peers are the five companies nearest above and the five nearest below Mana Pharma by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Mana Pharma Private Limited
Mana Pharma Private Limited is audited by RAM SANDEEP & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAM SANDEEP & ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Mana Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Mana Pharma Private Limited
Open charges
₹15.18 Cr
Satisfied charges
₹28.35 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Oct 2024 | Others | ₹15 Cr | Open |
| 23 Mar 2022 | Hdfc Bank Limited | ₹18.4 Lakh | Open |
| 27 Sep 2023 | Hdfc Bank Limited | ₹8 Cr | Satisfied |
| 20 Apr 2021 | Others | ₹19 Cr | Satisfied |
| 20 Mar 2021 | Hdfc Bank Limited | ₹1.35 Cr | Satisfied |
Total charge records: 5 View all charges
Employees and EPFO Compliance at Mana Pharma Private Limited
Employment history and EPFO contributions of people linked to Mana Pharma.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Mana Pharma Private Limited
Mana Pharma Private Limited has 5 board changes on record since 2019: 2 appointments and 3 cessations. The latest: Sailaja Bharatala ceased to be Director on 30 Sep 2023.
AGM
Mana Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Mana Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge registered on 27 Sep 2023 via Charge ID 100815032 with Hdfc Bank Limited was fully satisfied on 02 Nov 2024.
Charges
A charge with Others amounted to Rs. 15.00 Cr with Charge ID 101011991 was registered on 21 Oct 2024.
Charges
A charge registered on 20 Apr 2021 via Charge ID 100442107 with Others was fully satisfied on 13 Nov 2023.
Ceased
Sailaja Bharatala ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 8.00 Cr with Charge ID 100815032 was registered on 27 Sep 2023.
Charges
A charge with Others of Rs. 19.00 Cr registered on 20 Apr 2021 with Charge ID 100442107 was modified on 26 Aug 2022.
Charges
A charge registered on 20 Mar 2021 via Charge ID 100428092 with Hdfc Bank Limited was fully satisfied on 23 Aug 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.18 Cr with Charge ID 100560900 was registered on 23 Mar 2022.
Charges
A charge with Others amounted to Rs. 19.00 Cr with Charge ID 100442107 was registered on 20 Apr 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1.35 Cr with Charge ID 100428092 was registered on 20 Mar 2021.
5 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Mana Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Mana Pharma Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Mana Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Mana Pharma Private Limited
Mana Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAMCM7302C1ZO | Telangana | Active | 18 Jul 2019 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Mana Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mana Pharma Private Limited
Mana Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 June 2019 (7+ years old) and is registered under CIN U24230TG2019PTC133266.
Mana Pharma reported revenue of ₹55.64 Cr for FY 2025 (down 23% YoY).
Mana Pharma has 2 current directors:
- Bhaskaraiah Marri - Director
- Sailaja Bharatala - Director
Mana Pharma reported a net profit of ₹32.1 Lakh (net margin 0.6%) and EBITDA of ₹1.55 Cr (EBITDA margin 2.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Mana Pharma is 31% over three years and 72% over five years. In the latest year (FY 2025) revenue fell 23%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Mana Pharma is 36AAMCM7302C1ZO, registered in Telangana.
The CIN (Corporate Identification Number) of Mana Pharma is U24230TG2019PTC133266. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mana Pharma was incorporated on 10 June 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Mana Pharma by revenue are Eurocrit Labs International Private Limited, Elixir Extracts Private Limited, CS Performance Chemicals Private Limited, Irrh Specialty Chemicals India Limited, Reshmika Minerals & Chemicals Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sailaja Bharatala ceased to be Director on 30 Sep 2023. Venkatanaga Kali Vetukuri Vara Prasada Raju ceased to be Director on 30 May 2020. Bhaskaraiah Marri ceased to be Director on 31 Mar 2020. Mana Pharma has 5 board changes on record in total.
Yes, Mana Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).